Market Overview:
Fibrin sealant is the adhesives that are biocompatible and biodegradable. The sealants consist of purified, virus-inactivated human fibrinogen, human thrombin and sometimes some of the added components like virus-inactivated human factor and bovine aprotinin. They are also called tissue adhesives, these components when combined, form a blood clot. The fibrin glue is used in surgeries like cardiovascular surgery, thoracic surgery, neurosurgery, dental surgery, and various others to seal the wound.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Baxter International Inc. (United States), CSL Behring (CSL Group) (United States), Ethicon US, LLC (United States), Asahi Kasei Medical Co., Ltd. (Japan), C. R. Bard, Inc. (United States), Tissuemed Ltd. (United Kingdom), Hualan Biological Engineering Inc. (China), Sea Run Holdings, Inc (United States)' and Shanghai RAAS Blood Products Co., Ltd. (China) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region or narrow down segments in the final scope subject to feasibility |
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics of major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Vendors landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Key Vendors of Fibrin Sealant Market Study:
Baxter International Inc. (United States), CSL Behring (CSL Group) (United States), Ethicon US, LLC (United States), Asahi Kasei Medical Co., Ltd. (Japan), C. R. Bard, Inc. (United States), Tissuemed Ltd. (United Kingdom), Hualan Biological Engineering Inc. (China), Sea Run Holdings, Inc (United States)' and Shanghai RAAS Blood Products Co., Ltd. (China)
Fibrin Sealant Market Segment Analysis
Scope | Sub-Segments |
---|
Application / End User | Hospital, Clinics and Others |
Surgery | Cardiovascular Surgery,Thoracic Surgery,Neurosurgery,Reconstructive Surgery,Others |
Packaging | 2mL/Set,4mL/Set,6mL/Set,10mL/Set |
Influencing Trend:
Continuous Research and Development in Surgical Equipment and Availability of Fibrin Sealants in Various Packaging Size
Market Growth Drivers:
Increasing Demand for Adhesives in Surgical Operations for Operated Wound Protection and Rising Hemostasis in Patients with Coagulation Disorders
Restraints:
Adverse Effects Involved with Use of Fibrin Sealant Might be the Hindrance for the Market and Stringent Regulatory Guidelines Regarding Fibrin Sealant
Opportunities:
Medical Advancement in Healthcare Sector along with Infrastructure Development will Boost the Market
. The Global Fibrin Sealant market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Fibrin Sealant market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Fibrin Sealant market.
Identification of total players or companies operating in the global market which is further concentrated to fewer or most impacting players which are considered under the reports scope. In order to make a priority list sorting is done based on revenue generated based on the latest reporting with the help of paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Fibrin Sealant Manufacturers, Fibrin Sealant International Traders, Fibrin Sealant Distributors and Suppliers, Research and Development Institutes, Potential Investors, Industry Associations, Regulatory Bodies, Upstream and Downstream Buyers and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.